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Summary Members of the homologous series of alkanediol dimethanesulphonates of general formula
H3C.SO20.(CH2)n.O.SO2.CH3 have been tested for their ability to produce DNA interstrand crosslinking and
DNA sequence selectivity of guanine-N7 alkylation. In a sensitive crosslinking gel assay the efficiency of DNA
interstrand crosslink formation, dependent on the ability of the alkylating moiety to span critical nucleophilic
distances within the DNA, was found at 6 h to be 1,6-hexanediol dimethanesulphonate (Hexa-DMS)
(n = 6)>methylene dimethanesulphonate (MDMS) (n = 1)> 1,8-octanediol dimethanesulphonate (Octa-DMS)
(n = 8)> Busulphan (n = 4). The DNA interstrand crosslinking produced by MDMS was not due to either of
its hydrolysis products, formaldehyde or methanesulphonic acid (MSA). In contrast the extent of monoalkyla-
tion at guanine-N7 as determined by a modified DNA sequencing technique was found to be Busul-
phan>>Hexa-DMS = Octa-DMS, with a sequence selectivity somewhat less than that of other chemo-
therapeutic alkylating agents such as nitrogen mustards. MDMS at high levels induced a non-specific
depurination as a result of the reduction in pH resulting from MSA release. More strikingly MDMS (and
MSA) produced a single strong site of guanine reaction (depurination) in a guanine-rich 276 base pair
fragment of pBR322 DNA in the sequence of 5'-ATGGTGG-3'. This was observed when non-specific
depurination was negligible and was not seen with formic acid. Thus structurally similar alkylating agents can
differ in their type and extent of DNA monoalkylation and interstrand crosslinking, and in some cases (e.g.
MDMS/MSA) produce reactions with a high degree of selectivity.
The homologous series of alkanediol dimethanesulphonates
of general formula H3C.SO2O.(CH2)n.OSO2.CH3 provides a
valuable system for the study of bifunctional reactivity with
key intracellular target sites. The best known agent of this
series, busulphan (n = 4) is one of the drugs of choice in the
treatment of chronic myeloid leukaemia (Galton, 1953;
Galton et al., 1958), and methylene dimethanesulphonate
(MDMS) (n = 1) has undergone clinical trials. Members of
the series have been shown to be active against a number of
experimental tumours, such as Walker 256 rodent carcinoma
(Haddow & Timmis, 1951) and Yoshida lymphosarcoma
(Bedford & Fox, 1983). The chemistry of these compounds is
well documented, and following alkylation of nucleophilic
sites their breakdown products are usually non toxic.
On the basis of limited chromatographic evidence it was
suggested that busulphan produced cross-linking in DNA
through a GG bridge (Brookes & Lawley, 1961). A diguanyl
derivative (1,4-di(guanin-7-yl)butane) after reaction of DNA
with busulphan has been isolated (Tong & Ludlum, 1980),
but no distinction could be made as to whether this was
derived from inter- or intrastrand crosslinking. Using alka-
line elution it was shown that the entire series of compounds
(n = 1-9), with the exception of ethylene dimethanesulphon-
ate (EDMS) (n = 2), were capable of producing DNA inter-
strand crosslinks in cells, with a maximal activity on an
equimolar basis with 1,6-hexanediol dimethanesulphonate
(Hexa-DMS) (n = 6) (Bedford & Fox, 1983). In addition,
following MDMS treatment a large amount of proteinase-
sensitive DNA-protein crosslinking was observed, which was
attributed to the action of the formaldehyde produced on
hydrolysis of the drug (Bedford & Fox, 1981). Further
studies indicated that the formation of MDMS-induced
DNA interstrand crosslinks, rather than formaldehyde induc-
ed DNA-protein crosslinks, is the most likely cytotoxic lesion
(O'Connor & Fox, 1987). DNA-protein crosslinks were also
observed with the higher members of the series (n = 7-9)
(Bedford & Fox, 1983). An approximate correlation between
the ability to form DNA-DNA interstrand crosslinks and in
vitro cytotoxicity was observed with the members of the
series, with the exception of 1,8-octanediol dimethanesul-
phonate (Octa-DMS) (n=8) which appeared to be more
highly cytotoxic than its ability to produce DNA-DNA inter-
strand crosslinks would suggest. The relative position of the
two alkylating centres within such bifunctional agents is of
importance with regard to their antitumour activity, and the
ability of the series of dimethanesulphonates to span only
selected target nucleophilic distances coupled with the avail-
ability and reactivity of these sites could be an important
factor in determining the crosslinking ability of such com-
pounds. In the present study, selected members of the series
[MDMS (n = 1), busulphan (n = 4), Hexa-DMS (n = 6) and
Octa-DMS (n = 8)] have been tested for their relative ability
to produce DNA interstrand crosslinks in a sensitive in vitro
system.
Since the guanine-N7 position of DNA is the major site of
base alkylation for most chemotherapeutic alkylating agents,
and busulphan was shown to be able to produce a diguanyl
derivative through two N7 positions in DNA, the sequence
selectivity of monoalkylation produced by dimethanesulpho-
nates at this site has also been determined.
Materials and methods
Chemicals
Busulphan was synthesised according to the method of Tim-
mis (1950), by the reaction of 1,4-butandiol and methanesul-
phonyl chloride. The other esters were synthesised according
to the method of Emmons and Ferris (1953) by the reaction
of the appropriate dibromoalkane with silver methanesulpho-
nate in acetonitrile solvent. The products were recrystallised
from hot ethanol and their purity was verified by melting
point and I.R. spectral absorption measurements.
Melphalan was obtained from Wellcome Foundation.
Concentrated methanesulphonic acid was purchased from
Sigma and formaldehyde was obtained from FSA Labora-
tory Supplies as a solution 38% w/v. Plasmid pBR322 DNA
and restriction endonucleases were purchased from NBL.
[y32P]-ATP (specific activity 5000 Ci mmol 1) was purchased
from Amersham. All the other reagents were of the greatest
available purity.
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12 All dimethanesulphonates were freshly dissolved in DMSO
at a concentration of250 mM and then diluted as appropriate
in alkylation buffer. Melphalan was diluted from a stock
solution 10mM in 0.1 M HCI stored frozen.
Interstrand crosslinking gel assay
The method has recently been described in detail (Hartley et
al., 1991). Briefly, HindIII digested pBR 322 DNA was 3p_
labelled at its 5' ends with T4 polynucleotide kinase and
y32P-ATP (Maxam & Gilbert, 1980). Alkylation was per-
formed in 25 mM triethanolamine, 1 mM EDTA, pH 7.2 at
37°C for different times at a dose of 1 mM. After precipita-
tion and washing, DNA was resuspended in 10 1tl of strand
separation buffer (30% DMSO, 1 mM EDTA, 0.04% xylene
cyanol), heated for 2' at 90°C and quickly chilled on ice. One
control DNA was resuspended in 10 gl of non denaturing
loading buffer (6.7% sucrose, 0.04% bromophenol blue,
0.04% xylene cyanol).
Samples were then loaded on a 0.8% agarose gel contain-
ing a tris-acetate buffer system. Gels were run overnight at
40V, dried and autoradiographed. The relative DNA double
and single strand band intensities were determined by micro-
densitometry using an LKB Ultrascan-XL laser densitomer.
Sequence specificity ofguanine-N7 alkylation
The method has been previously described in detail (Mattes
et al., 1986). BamHl digested pBR 322 DNA was 32P-ATP-
labelled at its 5' ends with T4 polynucleotide kinase and
'y32P-ATP. A second cut with Sall was performed to produce
a 276 bp fragment labelled at only one end which was eluted
from agarose gel with a preparative gel electrophoresis
system (BRL). Alkylation was performed in 25 mM trietha-
nolamine, 1 mM EDTA, pH 7.2 at 37°C for 1 h at doses
selected to give no more than one alkylation per DNA
molecule. After precipitation and washing the DNA was
treated for 15' at 90°C with 1 M piperidine to produce breaks
quantitatively at sites ofguanine-N7 alkylation (Mattes et al.,
1986).
DNA fragments were separated on 0.4 mm 6% polyacryl-
amide gels containing 7 M urea and a Tris-boric acid-EDTA
buffer system. Gels were run at 3000 V for approximately
4 h, dried and autoradiographed. Relative band intensities
were determined by microdensitometry.
Results
Figure 1 shows a typical crosslinking gel of the four dimeth-
anesulphonates after 16 h treatment at a dose of 1 mM. All
the drugs can produce DNA interstrand crosslinks, but only
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Figure 2 Time course of DNA interstrand crosslinks produced
by treatment at 37°C. * = MDMS 1 mM; 0 = Busulphan 1 mM;
0 = Hexa-DMS 1 mM; 0 = Octa-DMS 1 mM.
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Figure I DNA interstrand crosslinks produced in linearised end-
labelled pBR322 following treatment for 16 h at 37°C: lane 1,
control DNA (undenaturing conditions); lane 2, control DNA
(denaturing conditions); lane 3, MDMS 1 mM; lane 4, Busulphan
1 mM; lane 5, Hexa-DMS 1 mM; lane 6, Octa-DMS 1 mM; lane
7, Formaldehyde 1 mM; lane 8, Methanesulphonic acid 2 mM.
Figure 3 Sites of guanine-N7 alkylation produced by I h treat-
ment at 37°C in a 276 base pair fragment of pBR322 DNA. The
base position and the runs of guanines are also indicated: lane 1,
Melphalan 2514m; lane 2, Busulphan 10mM; lane 3, Hexa-DMS
10 mM; lane 4, Octa-DMS 10 mM; lane 5, control; lane 6,
MDMS 5mM.DNA REACTIONS OF DIMETHANESULPHONATES 745
detectable at mM concentrations of the drugs. Since the half
life of MDMS in aqueous solution is 22 min, the effect of the
breakdown products of this compound (1 mM formaldehyde,
2 mM methanesulphonic acid) is also shown. Neither hydro-
lysis product produced any detectable level of interstrand
crosslinking. A time course of DNA interstrand crosslink
formation, with a continuous treatment up to 24 h at 1 mM,
is shown in Figure 2.
Crosslinking is still increasing at 24h with Hexa-DMS,
Octa-DMS and busulphan, but reaches a maximum with
MDMS at 12-15 h. At 6 h, when crosslinking of MDMS has
not yet reached a plateau, the efficiency of interstrand cross-
link formation is found to be: Hexa-DMS>MDMS>Octa-
DMS>busulphan.
Since the major site of alkylation on DNA for most
chemotherapeutic alkylating agents is the N7-position of
guanine, the pattern of alkylation of the four dimethanesul-
phonates with N7-guanine in a defined DNA segnent was
determined (Figure 3). In contrast to the crosslinking ability,
the extent of monoalkylation at N7-guanine at an equimolar
dose is: busulphan>>Hexa-DMS = Octa-DMS, with no
visible alkylation of the latter two agents under the condi-
tions shown in Figure 3. The reactivity of the drugs is
however very low, since a dose of busulphan of 10 mM
(Figure 3, lane 2) is required to give a similar extent of
alkylation to 25 fLM melphalan (Figure 3, lane 1), and under
these conditions the extent of guanine-N7 alkylation is at
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most 1 per DNA molecule. The microdensitometric scanning
of the gel autoradiogram (Figure 4) shows that the sequence
selectivity of busulphan (Figure 4, panel 2) was somewhat
less than that of melphalan (Figure 4, panel 1). Under iden-
tical conditions MDMS (Figure 3, lane 6; Figure 4, panel 5)
induces a non-specific depurination with a single strong site
of guanine reaction within the 276 base pair fragment at
guanine 517 in the sequence 5'-ATGGTGG-3'. A small
number of other such sites are observed in the whole pBR322
DNA (4363 base pairs, data not shown).
In order to characterise better the unique sequence selec-
tivity of reaction shown by MDMS, the effect of reaction
time and drug concentration was determined (Figure 5, left
panel). The strong site of reaction at G517 observed at 5 mM
for 1 h (Figure 5, lane 3) was also clearly evident following a
30 min treatment (Figure 5, lane 2), but not when the time
was shortened to 10min (Figure 5, lane 1). Reaction at this
site was demonstrated when the dose was reduced to 2.5 mM
(Figure 5, lane 4) but not at 0.5 mM (Figure 5, lane 5). The
corresponding densitometric traces (Figure 6) indicate that
the optimum conditions for generation of the unique reaction
site with minimal background depurination is 1 h at 2.5 mM
(Figure 6, panel 3). The pattern of reaction produced by
MDMS and its two hydrolysis products, formaldehyde and
a 1 2 3 4 5 6 7 b 1 2 3
G3
518 538
458 478
QATaGGGAAQ ATC(.CTCa CCACTTCGGG
498
CTCAT AgCa CTTGTTCQGC aT.G.TATC
518 5s3
TMGCAGCCC aTaQCCaGGG QACT!TTCGG
Figure 4 Densitometric scanning of gel in Figure 3: panel 1,
Melphalan 25 m; panel 2, Busulphan 10mM; panel 3, Hexa-
DMS l0 mM; panel 4, Octa-DMS l0 mM; panel 5, MDMS
5 mM. The base position and sequence of DNA is also indicated.
Figure 5 Reaction of MDMS and its hydrolysis products at
37C in a 276 base pair fragment of pBR322 DNA. a, lane 1,
MDMS 5 mM 10'; lane 2, MDMS 5 mM 30'; lane 3, MDMS
5 mM h; lane 4, MDMS 2.5 mM I h; lane 5, MDMS 0.5 mM
I h; lane 6, control; lane 7, Melphalan 25 jiM h. b, lane 1,
MDMS 5 mM h; lane 2, formaldehyde 5 mM h; lane 3,
methanesulphonic acid 10mM I h.
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Figure 6 Densitometric scanning of gel in Figure 5. Panel 1,
MDMS 5 mM 30'; panel 2, MDMS 5 mM I h; panel 3, MDMS
2.5 mM I h; panel 4, formaldehyde 5 mM I h, panel 5, methane-
sulphonic acid 1O mM I h; panel 6, formic acid 7'.
methanesulphonic acid (MSA), were also compared (Figure
5, right panel and corresponding scans, Figure 6). While
formaldehyde does not appear to react, methanesulphonic
acid produced the same pattern at MDMS, with both the
non-specific depurination and the strong site of reaction at
guanine 517.
The above experiments were performed in 25 mM trietha-
nolamine, the buffering capacity of which was low such that
the release of MSA on hydrolysis of MDMS could reduce
the pH sufficiently (<3.5) to cause some acid depurination
of the DNA. The unique site of reaction at guanine 517 was
strongly observed, however, under- conditions where the pH
did not drop sufficiently to produce any general acid depur-
ination (e.g. 2.5 mM MDMS, 1 h). Repeating this drug
exposure in buffers of greater buffering capacity it is evident
that this unique reaction is not observed when the pH is
maintained at 7 (data not shown). It therefore appears that a
moderate MSA-induced pH reduction can produce this uni-
que selectivity. Formic acid, however, which is used to
depurinate in the Maxam and Gilbert sequencing reaction,
does not produce the same unique reactivity at this site
(Figure 6, panel 6), even under equivalent pH conditions.
Discussion
Using a sensitive in vitro crosslinking assay the four members
of the homologous series ofalkanediol dimethanesulphonates
were shown to produce DNA interstrand crosslinks. Rela-
tively high concentrations of drug (>1 mM) were required
for many hours to produce 5-15% crosslinked DNA and the
agents are thus much less efficient crosslinking agents com-
pared to other bifunctional chemotherapeutic alkylating
agents such as nitrogen mustards. For example, under iden-
tical conditions mechlorethamine is able to crosslink 65% of
the DNA after a 1 h treatment at 1OgM (Hartley et al.,
1991). The kinetics of crosslink formation was found to vary
between different dimethanesulphonates as would be expected
from their abilities to span different nucleophilic distances
between the opposite strands of the DNA. In most cases the
rate of crosslink formation was very slow and still increasing
at 24 h which is in contrast to agents such as mechloreth-
amine which reaches a plateau within 1 h, or other mustards
with a much slower second arm reaction, such as melphalan,
which reach a plateau at 6 h (Hartley et al., 1991). The
exception was MDMS which reached a plateau of crosslink-
ing after 12 h which probably reflects its short half life in
aqueous solution (22 min, Fox & Jackson, 1965). The small
(-2.2A) 1 carbon crosslink clearly produced by MDMS and
not by either of its hydrolysis products, formaldehyde or
MSA, could be envisaged as a result of substitution for a
hydrogen bond between the DNA strands. The local denatur-
ation of DNA reported after treatment of calf thymus DNA
with MDMS may be a consequence of such an interaction
(Poppitt & Fox, 1975).
It is interesting to note that the relative interstrand cross-
linking ability of the four agents studied in vitro is the same
as that observed in cells using the technique of alkaline
elution at 4 h after a 1 h treatment with drug (Bedford &
Fox, 1983), suggesting that in cells differences in crosslinking
ability for these agents reflects their structural differences and
not primarily pharmacological or biochemical differences.
The in vitro DNA interstrand crosslinking gel assay
employed in the present investigation is very sensitive, accu-
rate enough for detailed time-course experiments, and partic-
ularly useful for agents such as the dimethane sulphonates
since previous attempts to identify interstrand crosslinking
after busulphan using classical physicochemical techniques
such as resistance to thermal denaturation of DNA (Kohn et
al., 1966), caesium chloride gradients (Verly & Brakier,
1969), and dispersion of DNA in high salt concentrations
(Alexander & Lett, 1960) failed due to both their insensitivity
and the low reactivity of busulphan with isolated DNA
(Brookes & Lawley, 1961).
The major site of base alkylation for most chemothera-
peutic alkylating agents, such as nitrogen mustards and chlo-
roethylnitrosoureas, is the N7 position of guanine and these
agents have recently been shown to react with DNA in a
sequence selective manner showing a general preference for
guanines in runs of guanines (Hartley et al., 1986; Mattes et
al., 1986). This is thought to be due in part to preferential
reaction of positively charged intermediates (such as the
aziridinium group of activated nitrogen mustards) with the
strongly negative molecular electrostatic potential in the in-
terior of G clusters (Kohn et al., 1987). In the present study
busulphan was shown to react at the guanine-N7 position
but with a sequence specificity somewhat less than that of
melphalan, which is consistent with the dimethanesulphonate
not producing a positively charged intermediate. Although
alkylation at guanine-N7 was observed with busulphan at
doses at which interstrand crosslinking occurred a GN7-GN7
interstrand crosslink is unlikely since the maximum extended
configuration of busulphan (6.OA) would be unable to span
the distance between N7 atoms on opposite strands (narrow
groove distance 8.OA using Dreiding models, B form DNA),
and the crosslinked adduct isolated by Tong and Ludlum
(1980) is most likely the result of an intrastrand crosslink.
Hexa-DMS (maximum extended configuration 8.5A) would
be ideally suited to span interstrand N7 distances, but neither
Hexa-DMS or Octa-DMS were seen to produce any signifi-
cant level ofguanine-N7 alkylation at doses at which efficient
crosslinking occurred, suggesting that crosslinking occurred
through other sites with these agents.
MDMS was unique in that it produced a pattern of bands
on the sequencing gels corresponding to guanines and aden-
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ines with a single site of strong guanine reaction in the
sequence 5'-ATGGTGG-3'. Both these effects were also pro-
duced by MSA and the time course indicated that the pattern
observed was caused by this breakdown product rather than
by MDMS itself. The non-specific depurination is clearly the
result of the reduction in pH resulting from MSA release.
Such a non-specific depurination reaction is the basis of the
formic acid purine lane in the Maxam and Gilbert sequenc-
ing procedure (Maxam & Gilbert, 1980). The single site of
reaction produced by MDMS/MSA appears to be due to a
less pronounced MSA-induced reduction in pH and is not
observed with formic acid. Thus some sequences appear to be
especially sensitive to MSA depurination. One possibility is
that the methanesulphonate anion is acting as a specific
nucleophile. However, the situation is complex since sodium
methanesulphonate is capable of producing the specific re-
action at G517, but only in buffer <pH 4 (data not shown),
whereas the pKa of MSA = -6.0.
The physiological significance of such a reaction is unclear
since such levels of drug, or such reductions in cellular pH,
would not be achieved clinically. However, the direct release
of MSA at the site of the DNA could induce specific re-
actions, or effect DNA conformation in certain sensitive
regions. In fact, in cells treated with MDMS, although for-
maldehyde is ultimately responsible for the DNA-protein
crosslinking observed, the differences in the pattern of cross-
linking between MDMS and formaldehyde have been shown
recently to be due to discrete changes in chromatin structure
induced directly by MSA release (O'Connor & Fox, 1989).
In conclusion a sensitive crosslinking gel assay was able to
follow the formation of DNA interstrand crosslinks pro-
duced in vitro by members of the series of dimethanesul-
phonates, and a modified DNA sequencing technique was
used to quantitate the monoalkylations produced at individ-
ual guanine-N7 positions, and to detect depurinations, within
a DNA sequence. These structurally similar agents were
found to differ in their kinetics and extent ofcrosslink forma-
tion and overall DNA alkylation, and in some cases (e.g.
MDMS/ MSA) produce reactions (depurinations) with a high
degree of selectivity.
This work was supported in part by the Cancer Research Campaign.
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